Technologies

Agilent Technologies releases automated literature search tool for biology researchers

Agilent Technologies Inc. (NYSE: A) today released an automated literature search tool for the multidisciplinary study of biological systems. The tool is available as a free plug-in to Cytoscape 2.1, an open-source bioinformatics platform that enables researchers to form a visual map of complex biological networks, increasing their understanding of molecular pathways and the biological causes of...

LUCA technologies confirms real-time methane generation

Luca Technologies LLC today announced that its researchers have confirmed the presence of a resident, methane-generating community of microorganisms ("microbial consortium") in substrate samples taken from the 110,000 acre Monument Butte oilfield located in North Eastern Utah. This site represents the latest in a series of active "GeobioreactorsTM" that Luca Technologies has identified since its...

Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays

Agilent Technologies Inc. (NYSE: A) today announced that it has for the first time released the chip design, probe sequence and annotation information for all of its microarrays. The release of this information is expected to improve cross-laboratory experimental research and cross-platform data comparison. "Full release of the probe sequences is an admirable and responsible position for A...

Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma

Agilent Technologies Inc. (NYSE: A) today announced that its breakthrough Human Genome CGH Microarray technology will be used by researchers at Melbourne's Peter MacCallum Cancer Centre in a three-year study designed to better understand mesothelioma, a cancer found in the lining of the chest, the abdominal cavity and around the heart, usually caused by exposure to asbestos. Due to its act...

Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research

Which is more likely to happen - you being in a car wreck or being bitten by a shark? Those who answered that cars are greater killers win a free trip to the beach. It's really no contest, says a Texas A&M University professor. Your chances of being in a wreck are far greater than being a shark's lunch, says John McEachran, a professor of wildlife and fishery sciences who has studied...

More>>

Technologies at Biology Products

S. pombe Whole Genome ChIP-on-chip from Agilent Technologies

Description:The S. pombe Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. pombe) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering both...
Company:Agilent Technologies

S. cerevisiae yeast Whole Genome from Agilent Technologies

Description:The Yeast Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. cerevisiae) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering bo...
Company:Agilent Technologies

S. cerevisiae yeast Whole Genome from Agilent Technologies

Description:The Yeast Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. cerevisiae) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering bo...
Company:Agilent Technologies

Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies

Description:The Rapid-Screen cDNA Library Panels were designed for full-length gene cloning and require just three sets of PCRs to identify the desired cDNA clone. The first PCR analysis is performed in a 96-well "Master Plate," where each well contains plasmid DNA from 5,000 clones. Having identified the positive well(s) by gel electrophoresis of the reaction products, the second PCR analysis is carried out...
Company:OriGene Technologies

Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Heart from OriGene Technologies

Description:The Rapid-Screen cDNA Library Panels were designed for full-length gene cloning and require just three sets of PCRs to identify the desired cDNA clone. The first PCR analysis is performed in a 96-well "Master Plate," where each well contains plasmid DNA from 5,000 clones. Having identified the positive well(s) by gel electrophoresis of the reaction products, the second PCR analysis is carried out...
Company:OriGene Technologies

More>>

Technologies at Biology Technology

Platypus Technologies receives $1.6 million NIH grant

The Small Business Innovation Research grant is for continued development of the company's proprietary liquid crystal based technology to enable faster screening of drugs for treatment of cancer. The com...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. s assets. Among the assets acquired from the British Colum...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. assets. Among the assets acquired from the British Colu...

Alliance Brings E-Business Technologies to Wisconsin Manufacturers

MADISON, Wis Small and mid-sized business in the state will soon be able to benefit from a new alliance announced today between Wisconsin Manufacturing Extension Partnership (WMEP) and the University of Wisconsin-Madisons Consortium for Global e-Commerce (UW CGEC) which will bring e-business technologies to local manufacturers. Helping Wisconsin manufacturers apply e-business technologie...

Barriers will not stop convergence of medical technologies

During residency, which is not the free-for-all carnival that Gray's Anatomy would have us believe, one of the most important judgment calls that is learned is whether the patien...

More>>

Technologies at Medicine News

Researchers Develop Technologies to Devour Food Pathogens

Purdue researchers are developing two inexpensive technologies that may be able to prevent future food-borne illness//, such as the recent outbreak of E. coli in contaminated spinach. Together, these technologies rapidly detect and eradicate food-borne pathogens. The first method uses a laser to detect and identify many types of bacteria, and is about three times faster and...

Researchers Study Safety of Assisted Reproductive Technologies

Researchers have found that Assisted Reproductive Technologies (ARTs) do not increase the risk of genetic mutations in developing fetuses//. Results of the study in mice will be released in this week’s journal, Proceedings of the National Academy of Sciences. “Although there have now been more than 3 million humans conceived by some form of ART, there have been very few studies of pot...

India to Propose Global Fund for Clean Energy Technologies

Calling itself a responsible nation towards climate change, India will propose a dedicated global fund at the G8 Outreach Summit Friday to finance the development of clean energy technologies based on the resources available with the developing world. In a position paper on climate change circulated ahead of the G8 Outreach Summit, India has said it has in place comprehensive polic...

Technologies at Medicine Products

VICTOR2 with fluorescence and luminescence technologies, stackers and robotic loading system

Description:This a new dedicated VICTOR2 model for fluorescence and luminescence detection with stacker and robotic loading....
Company:PerkinElmer Life And Analytical Sciences, Inc.

VICTOR2 V (5 technologies), manual model

Description:VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. A red-sensitive PMT enables LANCE assay. All technologies needed for non-radioactive detection are available in one small unit....
Company:PerkinElmer Life And Analytical Sciences, Inc.

VICTOR2 V (5 technologies) with stackers and robotic loading

Description:VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature control and stackers and a robotic loading system....
Company:PerkinElmer Life And Analytical Sciences, Inc.

Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies

Description:This new dedicated VICTOR2 model is for fluorescence, fluorescence polarization and luminescence measurements....
Company:PerkinElmer Life And Analytical Sciences, Inc.

Manual VICTOR2 with fluorescence and luminescence technologies

Description:This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
Company:PerkinElmer Life And Analytical Sciences, Inc.

More>>

Technologies at Medicine Technology

Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 9, 2007 - Neose Technologies,Inc. (NasdaqGM:NTEC) announced today that it will present at theC.E. Unterberg, Towbin Emerging Growth Opportunities Conferenceheld at the Mandarin Oriental Hotel in New York City from July10-12, 2007. The Company's presentation is scheduled for 2:00 p.m.(EDT) on Tuesday, July 10, 2007. The presentation will be webcastlive and...

New Report 'Looking at Chiral Technologies' Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals

DUBLIN, Ireland--(BUSINESS WIRE)--Jun 21, 2007 - Research andMarkets (http://www.researchandmarkets.com/reports/c60415) hasannounced the addition of Looking at Chiral Technologies to theiroffering. The advancements in molecular research and continued untiringefforts of the research industry to develop better more preciselyapplicable Pharmaceuticals as well as agro compounds would have not...

ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting

MONTREAL, June 19 /CNW/ - ConjuChem Biotechnologies (TSX:CJB)today announced that data relating to its proprietaryPC-DAC(TM):Exendin-4 Albumin Conjugate for the treatment ofType 2 diabetes will be presented at the 67th ScientificSessions of the American Diabetes Association (ADA) to beheld June 22-26, 2007 in Chicago, IL. The ADA's annualScientific Sessions meeting is one of the larges...

Theratechnologies: TH9507 Phase 3 Clinical Update

- Data from first Phase 3 trial presented at ENDO 2007 - Regulatory approvals for second Phase 3 trial open the door forpatient recruitment in Europe MONTREAL, QUEBEC -- (MARKET WIRE) -- June 04, 2007 --Theratechnologies (TSX: TH) reported today that 26-week data fromits first Phase 3 study testing TH9507 in HIV-associatedlipodystrophy were presented today in Toronto...

News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics

SAN MARINO, Calif., June 04, 2007 /PRNewswire/ -- (SEND2PRESSNEWSWIRE) -- Epeius Biotechnologies Corporation today announced thepublication of a historic landmark in medical oncology and adefinitive benchmark in the emerging field of cancer gene therapy.The first clinical report of its kind, Le Morte du Tumour --published in the June issue of the International Journal ofOncology, Vol.30,...

More>>